骶神经刺激治疗帕金森病合并膀胱过度活动症
随访22.2±7.8个月无需翻修或取出,提示SNS有效,但尿动力学梗阻参数可能预测失败。
要点
- 随访22.2±7.8个月无翻修或取出,SNS安全有效。
核心结论
- PD患者SNS进展至二期的比例与普通人群相似,SNS是PD合并OAB的有效治疗选择。
- 与梗阻相关的尿动力学参数可能预测SNS失败,有助于患者选择,但需进一步研究。
研究设计与样本
- 回顾性 review 了接受一期SNS的PD患者,共15例,分析人口学、尿动力学及基线排尿功能数据。
- 通过进展至二期、装置取出和手术翻修率评估疗效与安全性,长期结局用排尿日记和/或门诊记录评估。
主要发现
- 一期成功与失败患者在年龄、BMI、合并症、PD病程或左旋多巴等效日剂量上无显著差异。
- 随访>12个月者平均每日排尿次数减少6次。
- 最新随访(22.2±7.8个月)无患者需翻修或取出装置。
临床怎么用
- SNS可考虑用于PD合并OAB症状患者,一期成功率与普通人群相似。
- 女性PD患者一期成功率可能更高,男性需更谨慎选择。
- 术前尿动力学检查提示梗阻者,SNS失败风险可能较高,可辅助患者选择。
局限性
- 回顾性研究,样本量小(15例),结论需更大样本验证。
- 尿动力学参数预测SNS失败的作用尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the efficacy, safety, and outcomes of sacral nerve stimulation (SNS) for Parkinson's disease (PD) patients with overactive bladder symptoms. METHODS: We retrospectively reviewed PD patients who underwent Stage I SNS. Demographics, urodynamic data, and baseline voiding function were analyzed. Efficacy and safety of treatment were determined by rate of progression to Stage II, explantation, and surgical revision. Long-term outcomes were assessed using voiding diaries and/or clinic notes. RESULTS: Sixty percent (9/15) experienced ≥50% improvement in urinary parameters and proceeded to Stage II. There was no significant difference in age, body mass index, comorbidities, PD disease duration, or levodopa equivalent daily dose between successful and nonsuccessful Stage I patients. However, 100% of female patients experienced Stage I success compared to 44% of male PD patients (P = .04). Individuals with >12-month follow-up experienced an average reduction of 6 voids/day. No patients required revision or explantation of their device at latest clinic follow-up (22.2 ± 7.8 months). Higher maximal urethral closure pressures, detrusor pressure at maximum flow rate (PdetQmax), post-void residual volume, and mean bladder outlet obstruction index were observed in the Stage I trial failures. CONCLUSION: At our institution, PD patients have a similar rate of progression to Stage II compared to the general population. SNS is an effective therapy that should be considered among the treatment options for PD patients with overactive bladder symptoms. Urodynamic parameters associated with obstruction may be predictive of SNS failure in PD patients and may help guide patient selection, however further studies are needed.
引用
- Greenberg DR, Sohlberg EM, Zhang CA, et al. Sacral Nerve Stimulation in Parkinson's Disease Patients With Overactive Bladder Symptoms. Urology. 2020. PMID: 32681915. doi:10.1016/j.urology.2020.06.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。